Recent years, many studies have found that aberrantly expressed ACAT2 is associated with carcinogenesis and progression, such as hepatocarcinoma [26], clear cell renal cell carcinoma [27], colorectal cancer [28], breast cancer [29], and so on. This evidence concerns the gene ACAT2 and breast carcinoma.